123ArticleOnline Logo
Welcome to 123ArticleOnline.com!

ALL >> Business >> View Article

Harver Group Investing Heavily In Potential Cancer Cure

By Author: Harver Group
Total Articles: 26

Jul. 22, 2013 - CHUO-KU, Japan -- Harvard Bioscience Inc. (HBIO) has received little attention for their research from the medical establishment or from educational institutions. While posting consistent growth and a strong customer base, shareholders have not seen much profit to date due to operating losses from the company´s Regenerative Medical Device division also known as Harvard Apparatus Regenerative Technology.

“We believe that Harvard Bioscience Inc. is a solid investment now” said Peter Anderson Senior Vice President of Mergers and Acquisitions at Harver Group, “before Harvard Apparatus Regenerative Technology is given an initial public offering”.

Head of Investment Analysis, Mr. Nathan Marx said “Removing Harvard Apparatus from their balance sheets should lead to an increase in valuation of at least 50% in the short term and potentially 100% in the long term if shareholder friendly policies are enacted. We expect the IPO to happen within four months”.

Harvard Apparatus Regenerative Technology is pursing ground breaking research; they are preforming clinical trials of their cure for trachea cancer. The trials have produced very exciting results, with a high survival rate for a typically fatal form of cancer. They’ve created scaffolding, which in conjunction with cells from the patient construct a new trachea. This technology has further applications, for lung and heart, heart valve, liver, and kidney transplants as well as esophageal cancer.

Both the President and CFO of Harvard Bioscience Inc. will be leaving to run Harvard Apparatus Regenerative Technology. We believe that this indicates that a sale of Harvard Bioscience is in the works, due to the fact that the President and CFO along with other members of management own 14% of the company. Management will likely maximize value, and sell the company for at least $10 a share. We are recommending our clients to move on Harvard Bioscience Inc. as soon as possible and we will bring more news on Harvard Apparatus Research Technology IPO as we receive it.

Total Views: 57Word Count: 321See All articles From Author

Business Articles

1. Low Deposit Home Loans Are Great For Those Who Search For Cheap Home Loans!
Author: Mc Cutcheon

2. Anti-theft Siren Alarm Padlocks For Your Potential Security Problems
Author: KINBARLOCK

3. What Are The Benefits Of Using Stainless Steel Fasteners In Various Industries?
Author: Sidharth Jain

4. Factors Affecting The Working Efficiency Of The Hex Nuts And Bolts
Author: Sidharth Jain

5. Reasons For Galvanic Corrosion Of A Hex Bolt And Its Prevention
Author: Sidharth Jain

6. Pharmaceutical Manufacturers|healthcare Products Manufacturers
Author: ichapps

7. All You Need To Know About Machine Screws
Author: Sidharth Jain

8. Amazing Benefits Of Having Custom Granny Flats
Author: James Raad

9. Guide To Buying Your Diamond Engagment/wedding Ring
Author: Alexander Pearce

10. Optik Pdx - Portland Eye Center Worth Your Time And Money
Author: davudobuya55

11. Ways To Get Personal Loan At Best Interest Rates
Author: IndiaLoanBazaar

12. Opportunities For The Global Structural Heart Device Market To Reach $9.7 Billion By 2022
Author: Roy Almaguer

13. What Comes After Perfection!
Author: Shalu Kansal

14. Big Data Simplified In The Easy Way
Author: Rimpy Sharma

15. Residential Real Estate Agent Dana Point Ca And Finding A Reliable Agent
Author: jonny smith


Login To Account
Login Email:
Password:
Forgot Password?
New User?
Sign Up Newsletter
Email Address: